An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival

  • Received: 01 October 2014 Accepted: 29 June 2018 Published: 01 August 2015
  • MSC : Primary: 92C37, 92C50; Secondary: 92C45.

  • Apoptosis resistance is a hallmark of human cancer, and tumor cells often become resistant due to defects in the programmed cell death machinery.Targeting key apoptosis regulators to overcome apoptotic resistance and promote rapid death of tumor cells is an exciting new strategy for cancer treatment, either alone or in combination with traditionally used anti-cancer drugs that target cell division. Here we present a multiscale modeling framework for investigating the synergism between traditional chemotherapy and targeted therapies aimed at critical regulators of apoptosis.

    Citation: Alexis B. Cook, Daniel R. Ziazadeh, Jianfeng Lu, Trachette L. Jackson. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival[J]. Mathematical Biosciences and Engineering, 2015, 12(6): 1219-1235. doi: 10.3934/mbe.2015.12.1219

    Related Papers:

  • Apoptosis resistance is a hallmark of human cancer, and tumor cells often become resistant due to defects in the programmed cell death machinery.Targeting key apoptosis regulators to overcome apoptotic resistance and promote rapid death of tumor cells is an exciting new strategy for cancer treatment, either alone or in combination with traditionally used anti-cancer drugs that target cell division. Here we present a multiscale modeling framework for investigating the synergism between traditional chemotherapy and targeted therapies aimed at critical regulators of apoptosis.


    加载中
    [1] Science, 281 (1998), 1322-1326.
    [2] PLoS One, 9 (2014), e99404.
    [3] Nature, 415 (2002), 922-926.
    [4] Oncogene, 27 (2009), S128-S136.
    [5] Annu. Rev. Immunol., 16 (1998), 395-419.
    [6] J. Biol. Chem., 269 (1994), 787-790.
    [7] Neoplasia, 5 (2003), 161-169.
    [8] Cancers, 3 (2011), 1351-1371.
    [9] Ann NY Acad Sci, 1010 (2003), 153-158.
    [10] Mol. Pharmacol., 59 (2001), 657-663.
    [11] PLoS One, 9 (2014), e81582.
    [12] Cancer Res., 71 (2011), 705-715.
    [13] Mol. Cancer There., 8 (2009), 2926-2936.
    [14] Bull. Math. Biol., 70 (2008), 89-117.
    [15] J Neurochem, 84 (2003), 273-281.
    [16] Chem. Rev., 107 (2007), 1387-1407.
    [17] J. Biol. Chem., 286 (2011), 14564-14574.
    [18] Clin. Cancer Res., 9 (2003), 4287-4295.
    [19] J. Exp Clin. Cancer Res., 31 (2012), p102.
    [20] Mol. Cell., 6 (2000), 1389-1399.
    [21] Mol. Cancer Ther., 8 (2009), 10-16.
    [22] Cancers, 3 (2011), 415-427.
    [23] Adv Studies in Biol, 4 (2012), 19-25.
    [24] Int. J. Oncol., 29 (2006), 471-479.
    [25] Nature, 407 (2000), 810-816.
    [26] Cancer Res., 73 (2013), 5485-5496.
    [27] Oncologist, 15 (2010), 994-1001.
    [28] Nat. Rev. Drug Discov., 1 (2002), 111-121.
    [29] Adv. in Pharm., 41 (1997), 501-532.
    [30] J. Clin. Oncol., 30 (2012), 488-496.
    [31] Clin. Cancer Res., 1 (1995), 981-989.
    [32] JNCI., 82 (1990), 749-755.
    [33] Adv. Cancer Res., 108 (2010), 73-112.
    [34] Hemotol., 1 (2005), 226-230.
    [35] Ind. Eng. Chem. Res., 50 (2011), 12872-12880.
    [36] Chem. Res. Toxicol., 17 (2004), 1434-1444.
    [37] Eur. J. Cancer, 28 (1992), 82-86.
    [38] Cancer Res., 68 (2008), 3421-3428.
    [39] Scient, 292 (2001), 727-730.
  • Reader Comments
  • © 2015 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(283) PDF downloads(499) Cited by(5)

Article outline

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog